Country for PR: United States
Contributor: PR Newswire New York
Wednesday, May 22 2019 - 01:05
AsiaNet
LifeScan Enters into Agreement with Sanvita Medical to Market and Distribute Continuous Glucose Monitoring (CGM) Devices
MALVERN, Pennsylvania, May 22, 2019 /PRNewswire-AsiaNet/--

-- The two diabetes device companies plan to launch CGM systems beginning in 
2020

LifeScan, a world leader in blood glucose monitoring and maker of the iconic 
OneTouch(R) brand, today announced it has entered into an exclusive agreement 
with Sanvita Medical, LLC, to market continuous glucose monitoring (CGM) 
sensors. Sanvita Medical is a subsidiary of Nova Biomedical Corporation, a 
world leader focused on accuracy and dependability in advanced technology blood 
testing analyzers and blood glucose monitoring. 

Logo - https://mma.prnewswire.com/media/749088/Lifescan_Logo.jpg 

Through this collaboration, the companies plan to launch CGM systems in North 
America and select countries in Europe as early as mid-next year and then 
expand into other markets around the world. The new CGM products will integrate 
with LifeScan's OneTouch Reveal(R) digital portfolio, including the OneTouch 
Reveal(R) app. 

"There is a huge unmet need in diabetes management, and as a world leader in 
diabetes care we are excited to collaborate with Sanvita to help patients 
address that need with CGM technologies designed specifically with their 
concerns and goals in mind," says Valerie Asbury, LifeScan President and CEO.  
"For LifeScan, this is a natural extension of our vision to create a world 
without limits for people with diabetes and a reinforcement of our unwavering 
commitment to diabetes care."

As a global leader in blood glucose monitoring and test strip manufacturing, 
the addition of CGM to LifeScan's product portfolio is part of the company's 
expansion and growth plans. The company has a long history of manufacturing and 
marketing blood glucose monitoring systems defined by simplicity, accuracy, and 
trust, including blood glucose meters, testing strips, lancets, point-of-care 
systems, and integrated digital solutions. "Soon we will be able to offer the 
spectrum of diabetes monitoring solutions--from our blood glucose monitoring 
systems to our digital products to CGM technologies with Sanvita," Asbury says.

About LifeScan
With a vision to create a world without limits for people with diabetes, 
LifeScan is a world leader in blood glucose monitoring - globally more than 20 
million people depend on OneTouch brand products to help them manage their 
diabetes. For over 35 years, LifeScan has had an unwavering commitment to 
improving the quality of life for people with diabetes by developing products 
defined by simplicity, accuracy, and trust. For more information, visit 
www.LifeScan.com and www.OneTouch.com.

SOURCE: Lifescan, Inc.

CONTACT: Bridget Doherty, (610) 428-0038, BDoherty@Lifescan.com
Translations

Japanese